Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease
- 1 June 2004
- journal article
- review article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 30 (3) , 255-266
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trialThe Lancet, 2002
- Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresisAtherosclerosis, 2002
- Influence of Serum Lipids on Auditory FunctionThe Laryngoscope, 2000
- Hyperlipoprotein(a)aemia in nephrotic syndromeEuropean Journal of Clinical Investigation, 1996
- LDL-apheresis: Clinical experience and indications in the treatment of severe hypercholesterolemiaTransfusion Science, 1993
- Complement activation and depletion during LDL‐apheresis by heparin‐induced extracorporeal LDL‐precipitation (HELP)European Journal of Clinical Investigation, 1991
- Selective removal of low density lipoproteins (LDL) by precipitation at low pH: First clinical application of the HELP systemJournal of Molecular Medicine, 1987
- Atherosclerosis and HemostasisSeminars in Thrombosis and Hemostasis, 1986
- The Efficacy of Steroids in the Treatment of Idiopathic Sudden Hearing Loss: A Double-blind Clinical StudyJAMA Otolaryngology–Head & Neck Surgery, 1980
- A NEW APPROACH TO THE MANAGEMENT OF FAMILIAL HYPERCHOLESTEROLqMIA: REMOVAL OF PLASMA-CHOLESTEROL BASED ON THE PRINCIPLE OF AFFINITY CHROMATOGRAPHYThe Lancet, 1976